4-(4-(methylsulfonyl)phenyl)morpholine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: 4-(4-(methylsulfonyl)phenyl)morpholine
• 英文别名: 4-(4-Methanesulfonyl-phenyl)-morpholine；4-(4-methylsulfonylphenyl)morpholine
• 化学式: C₁₁H₁₅NO₃S
• mdl: MFCD03648543
• 分子量: 241.311
• InChiKey: SZWGFBHKQBHORQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.454
• 拓扑面积：
  55
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  4-(4-氯苯基)吗啉 、 sodium methansulfinate 在 potassium phosphate 、 copper(l) iodide 、 (2S,4R)-4-hydroxy-N-(2-methylnaphthalen-1-yl)pyrrolidine-2-carboxamide 作用下， 以 二甲基亚砜 为溶剂， 以96%的产率得到4-(4-(methylsulfonyl)phenyl)morpholine
  参考文献：
  名称：

  新型酰胺配体实现了亚甲基磺酸钠与（杂）芳基氯化物的铜催化偶联

  摘要：

  （（2 S，4 R）-4-羟基N-（2-甲基萘-1-基）吡咯烷-2-羧酰胺（HMNPC），一种由4-羟基-L脯氨酸和2-甲基萘衍生的酰胺1-胺是（杂）芳基卤化物与亚磺酸盐的Cu催化偶联的强配体，首次使（杂）芳基氯化物与NaSO 2 Me发生金属催化偶联。 ）芳基氯化物的效果很好，以良好的收率提供了药学上重要的（杂）芳基甲基砜。

  DOI：

  10.1002/cjoc.201700477

文献信息

• HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE
  申请人：CE Pharm CO., LTD.

  公开号：US20190127337A1

  公开（公告）日：2019-05-02

  Provided are a heterocyclic carboxylic acid amide ligand and applications thereof in a copper catalyzed coupling reaction. Specifically, provided are uses of a compound represented by formula (I), definitions of radical groups being described in the specifications. The compound represented by formula (I) can be used as the ligand in the copper catalyzed coupling reaction of the aryl halogeno substitute, and is used or catalyzing the coupling reaction for forming the aryl halogeno substitute having C—N, C—O, C—S and other bonds.

  提供了一种杂环羧酸酰胺配体及其在铜催化的偶联反应中的应用。具体地，提供了一种由公式(I)表示的化合物的用途，其中自由基组的定义在说明书中有所描述。由公式(I)表示的化合物可作为铜催化偶联反应中芳基卤素取代物的配体，并用于催化形成具有C-N、C-O、C-S等键的芳基卤素取代物的偶联反应。
• Nickel‐Catalyzed Amination of (Hetero)aryl Halides Facilitated by a Catalytic Pyridinium Additive
  作者：Dongyang Han、Sasa Li、Siqi Xia、Mincong Su、Jian Jin

  DOI：10.1002/chem.202002800

  日期：2020.9.25

  An efficient and operationally simple Ni‐catalyzed amination protocol has been developed. This methodology features a simple NiII salt, an organic base and catalytic amounts of both a pyridinium additive and Zn metal. A diverse number of (hetero)aryl halides were coupled successfully with primary and secondary alkyl amines, and anilines in good to excellent yields. Similarly, benzophenone imine gave

  已经开发了有效且操作简单的镍催化胺化方案。该方法具有简单的Ni II盐，有机碱以及催化量的吡啶鎓添加剂和Zn金属的特征。多种（杂）芳基卤化物与伯，仲烷基胺和苯胺成功偶联，收率良好。同样，二苯甲酮亚胺以优异的收率得到了相应的N芳基化产物。
• Direct sulfonylation of anilines mediated by visible light
  作者：Tarn C. Johnson、Bryony L. Elbert、Alistair J. M. Farley、Timothy W. Gorman、Christophe Genicot、Bénédicte Lallemand、Patrick Pasau、Jakub Flasz、José L. Castro、Malcolm MacCoss、Darren J. Dixon、Robert S. Paton、Christopher J. Schofield、Martin D. Smith、Michael C. Willis

  DOI：10.1039/c7sc03891g

  日期：——

  biologically active molecules and are key functional groups for organic synthesis. We report a mild, photoredox-catalyzed reaction for sulfonylation of aniline derivatives with sulfinate salts, and demonstrate the utility of the method by the late-stage functionalization of drugs. Key features of the method are the straightforward generation of sulfonyl radicals from bench-stable sulfinate salts and the

  砜在生物活性分子中具有显着特征，并且是有机合成的关键功能基团。我们报告了一个温和的，光氧化还原催化的亚磺酸盐与苯胺衍生物的磺酰化反应，并通过药物的后期功能化证明了该方法的实用性。该方法的主要特点是可以从稳定的亚磺酸盐直接生成磺酰基，并使用简单的苯胺衍生物作为便捷的偶联剂。
• OXIME COMPOUNDS AND THE USE THEREOF
  申请人：Matsumura Akira

  公开号：US20090298878A1

  公开（公告）日：2009-12-03

  The invention relates to oxime compounds of Formula (I) and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein X is hydrogen, optionally substituted aryl, optionally substituted heteroaryl or the like; Y is CO, SO 2 , CR 3 R 4 or the like; Z is optionally substituted lower alkyl, optionally substituted aryl or the like; W is optionally substituted lower alkylene or optionally substituted lower alkenylene, R 3 and R 4 are each independently hydrogen, lower alkyl or the like; p is 0, 1, or 2 and q is 0, 1 or 2. The invention is also directed to the use compounds of Formula I to treat, prevent or ameliorate a disorder responsive to the blockade of calcium channels, and particularly N-type calcium channels. Compounds of the present invention are especially useful for treating pain.

  本发明涉及式(I)的肟化合物及其药学上可接受的盐、前药或溶剂，其中X为氢、可选取代芳基、可选取代杂环基或类似物；Y为CO、SO2、CR3R4或类似物；Z为可选取代的低烷基、可选取代的芳基或类似物；W为可选取代的低烷基或可选取代的低烯基，R3和R4各自独立地为氢、低烷基或类似物；p为0、1或2，q为0、1或2。本发明还涉及使用式(I)的化合物来治疗、预防或改善对钙通道封锁有反应的疾病，特别是N型钙通道。本发明的化合物特别适用于治疗疼痛。
• Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute
  申请人：CE Pharm CO., LTD.

  公开号：US10759765B2

  公开（公告）日：2020-09-01

  Provided are a heterocyclic carboxylic acid amide ligand and applications thereof in a copper catalyzed coupling reaction. Specifically, provided are uses of a compound represented by formula (I), definitions of radical groups being described in the specifications. The compound represented by formula (I) can be used as the ligand in the copper catalyzed coupling reaction of the aryl halogeno substitute, and is used or catalyzing the coupling reaction for forming the aryl halogeno substitute having C—N, C—O, C—S and other bonds.

  本发明提供了一种杂环羧酸酰胺配体及其在铜催化偶联反应中的应用。具体而言，提供了由式（I）代表的化合物的用途，基团的定义在说明书中描述。式（I）代表的化合物可用作铜催化卤代芳基化合物偶联反应中的配体，用于或催化偶联反应以形成具有 C-N、C-O、C-S 和其他键的卤代芳基化合物。